STERITALC Drug Patent Profile
✉ Email this page to a colleague
When do Steritalc patents expire, and when can generic versions of Steritalc launch?
Steritalc is a drug marketed by Novatech Sa and is included in one NDA.
The generic ingredient in STERITALC is talc. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the talc profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Steritalc
A generic version of STERITALC was approved as talc by SCIARRA LABS on December 15th, 2003.
Summary for STERITALC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in STERITALC? | STERITALC excipients list |
| DailyMed Link: | STERITALC at DailyMed |
US Patents and Regulatory Information for STERITALC
STERITALC is protected by zero US patents and two FDA Regulatory Exclusivities.
FDA Regulatory Exclusivity protecting STERITALC
TO DECREASE THE RECURRENCE OF MALIGNANT PLEURAL EFFUSIONS IN SYMPTOMATIC PATIENTS FOLLOWING MAXIMAL DRAINAGE OF THE PLEURAL EFFUSION
Exclusivity Expiration: ⤷ Try a Trial
TO DECREASE THE RECURRENCE OF PNEUMOTHORAX IN ADULTS
Exclusivity Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novatech Sa | STERITALC | talc | POWDER;INTRAPLEURAL | 205555-001 | May 1, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Novatech Sa | STERITALC | talc | POWDER;INTRAPLEURAL | 205555-002 | May 1, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Novatech Sa | STERITALC | talc | POWDER;INTRAPLEURAL | 205555-003 | May 1, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
